Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thyroid Gland Papillary Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT05500508
What this trial is testing

Oral AMXT 1501 Dicaprate in Combination With IV DFMO

Who this might be right for
CancerSolid TumorSolid Carcinoma+17 more
Aminex Therapeutics, Inc. 15
Not applicableLooking for participantsNCT06730321
What this trial is testing

Surgical Competency for Robot-Assisted Thyroidectomy: Construction and Validation of a Robotic Thyroidectomy Assessment Score (RTAS)

Who this might be right for
Thyroid CancerThyroid NoduleThyroid Diseases+2 more
Shanghai 6th People's Hospital 200
Not applicableActive Not RecruitingNCT02776969
What this trial is testing

A Gene Hunting Study for Familial Papillary Thyroid Cancer

Who this might be right for
Thyroid
Ohio State University Comprehensive Cancer Center 1,200
Not applicableStudy completedNCT05760690
What this trial is testing

Safety of Endoscopic Thyroidectomy Via Retro-Auricular Single-Site Approach, Transoral Approach and Transareola

Who this might be right for
Papillary Thyroid Carcinoma
Sun Yat-sen University 160
Not applicableStudy completedNCT06068101
What this trial is testing

Clinical and Genetic Investigation of the Association Between Primary Aldosteronism and Thyroid Cancer

Who this might be right for
Thyroid Cancer, PapillaryPrimary Aldosteronism
Instituto do Cancer do Estado de São Paulo 274
Not applicableLooking for participantsNCT05024929
What this trial is testing

Targeted Therapy to Increase RAI Uptake in Metastatic DTC

Who this might be right for
Papillary Thyroid CancerPediatric CancerDifferentiated Thyroid Cancer
Children's Hospital of Philadelphia 32
Not applicableLooking for participantsNCT05962892
What this trial is testing

Factors Influencing Recurrence After Thermal Ablation of Papillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid CarcinomaThermal Ablation
Beijing Friendship Hospital 600
Early research (Phase 1)Study completedNCT03470259
What this trial is testing

Precision Thyroid Cancer Surgery With Molecular Fluorescent Guided Imaging

Who this might be right for
Papillary Thyroid CancerLymph Node Metastases
University Medical Center Groningen 19
Not applicableNot Yet RecruitingNCT07529080
What this trial is testing

Personalized Cancer Support (Thrive Track) to Manage the Emotional Needs of Young Adults With Thyroid, Melanoma and Testicular Cancer, PerCS-YA Trial

Who this might be right for
Differentiated Thyroid Gland CarcinomaMalignant Testicular NeoplasmMelanoma+2 more
University of Michigan Rogel Cancer Center 142
Not applicableUnknownNCT04411290
What this trial is testing

Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases

Who this might be right for
Thyroid CarcinomaThyroid Papillary CarcinomaMultinodular Goiter, Adolescent+8 more
Umraniye Education and Research Hospital 200
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Early research (Phase 1)Study completedNCT01413113
What this trial is testing

Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery

Who this might be right for
Recurrent Thyroid CancerStage IVA Follicular Thyroid CancerStage IVA Papillary Thyroid Cancer+4 more
University of Washington 6
Not applicableNot Yet RecruitingNCT03813173
What this trial is testing

Central Cervical Dissection for Clinical Node Negative Papillary Thyroid Carcinoma

Who this might be right for
Lymph Node Metastases
Zhejiang University 6,000
Testing effectiveness (Phase 2)Active Not RecruitingNCT03157128
What this trial is testing

Selpercatinib (LOXO-292) in Participants With Advanced Solid Tumors, RET Fusion-Positive Solid Tumors, and Medullary Thyroid Cancer (LIBRETTO-001)

Who this might be right for
Non-Small Cell Lung CancerMedullary Thyroid CancerColon Cancer+1 more
Eli Lilly and Company 857
Not applicableStudy completedNCT07107503
What this trial is testing

10 Years' Follow-up Results of Ultrasound-guided Radiofrequency Ablation Versus Surgery for Low-risk Papillary Thyroid Micro-carcinoma

Who this might be right for
Papillary Thyroid MicrocarcinomaRadiofrequency AblationSurgical Resection+1 more
Yi Mao 757
Not applicableStudy completedNCT02561533
What this trial is testing

Detection of BRAF Mutation on FNAB From Papillary Thyroid Carcinoma

Who this might be right for
Papillary Thyroid Carcinoma
University of Aarhus 53
Testing effectiveness (Phase 2)Looking for participantsNCT06087068
What this trial is testing

Thyroxine Replacement Therapy After Lobectomy for Low-risk Papillary Thyroid Carcinoma

Who this might be right for
Thyroid CancerSurgeryRecurrence
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 140
Testing effectiveness (Phase 2)Study completedNCT02393690
What this trial is testing

Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer

Who this might be right for
Metastatic Thyroid Gland CarcinomaPoorly Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland Carcinoma+8 more
Academic and Community Cancer Research United 60
Early research (Phase 1)Study completedNCT04462471
What this trial is testing

Vemurafenib Plus Copanlisib in Radioiodine-Refractory (RAIR) Thyroid Cancers

Who this might be right for
Thyroid CarcinomaThyroid CancerThyroid Cancer, Follicular+3 more
Memorial Sloan Kettering Cancer Center 8
Testing effectiveness (Phase 2)Active Not RecruitingNCT04544111
What this trial is testing

PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer

Who this might be right for
Thyroid CancerThyroid Cancer, FollicularPapillary Thyroid Cancer+4 more
Memorial Sloan Kettering Cancer Center 19
Next Page